These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 11580994)

  • 1. Haemodynamic changes following treatment of subclinical and overt hyperthyroidism.
    Faber J; Wiinberg N; Schifter S; Mehlsen J
    Eur J Endocrinol; 2001 Oct; 145(4):391-6. PubMed ID: 11580994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women.
    Faber J; Jensen IW; Petersen L; Nygaard B; Hegedüs L; Siersbaek-Nielsen K
    Clin Endocrinol (Oxf); 1998 Mar; 48(3):285-90. PubMed ID: 9578817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres.
    Silva MN; Rubió IG; Romão R; Gebrin EM; Buchpiguel C; Tomimori E; Camargo R; Cardia MS; Medeiros-Neto G
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic changes after levothyroxine treatment in subclinical hypothyroidism.
    Faber J; Petersen L; Wiinberg N; Schifter S; Mehlsen J
    Thyroid; 2002 Apr; 12(4):319-24. PubMed ID: 12034057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
    Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
    Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of subclinical hyperthyroidism and relationship between thyroid hormonal status and thyroid ultrasonographic parameters in patients with non-toxic nodular goitre.
    Rieu M; Bekka S; Sambor B; Berrod JL; Fombeur JP
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):67-71. PubMed ID: 8348708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observations concerning the natural history of subclinical hyperthyroidism.
    Woeber KA
    Thyroid; 2005 Jul; 15(7):687-91. PubMed ID: 16053385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
    Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elderly patients with suppressed serum TSH but normal free thyroid hormone levels usually have mild thyroid overactivity and are at increased risk of developing overt hyperthyroidism.
    Stott DJ; McLellan AR; Finlayson J; Chu P; Alexander WD
    Q J Med; 1991 Jan; 78(285):77-84. PubMed ID: 1670067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical evaluation of patients with subclinical hyperthyroidism and free triiodothyronine (free T3) toxicosis.
    Figge J; Leinung M; Goodman AD; Izquierdo R; Mydosh T; Gates S; Line B; Lee DW
    Am J Med; 1994 Mar; 96(3):229-34. PubMed ID: 8154510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical Graves' disease as a cause of subnormal TSH levels in euthyroid subjects.
    Kasagi K; Takeuchi R; Misaki T; Kousaka T; Miyamoto S; Iida Y; Konishi J
    J Endocrinol Invest; 1997 Apr; 20(4):183-8. PubMed ID: 9211123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states.
    Schultz M; Faber J; Kistorp C; Jarløv A; Pedersen F; Wiinberg N; Hildebrandt P
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):54-9. PubMed ID: 14678288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
    Chen JJ; Ladenson PW
    J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The many causes of subclinical hyperthyroidism.
    Charkes ND
    Thyroid; 1996 Oct; 6(5):391-6. PubMed ID: 8936661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients.
    Biondi B; Palmieri EA; Fazio S; Cosco C; Nocera M; Saccà L; Filetti S; Lombardi G; Perticone F
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4701-5. PubMed ID: 11134131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe but not mild alterations of thyroid function modulate the density of thyroid-stimulating hormone receptors in the rat thyroid gland.
    Denereaz N; Lemarchand-Beraud T
    Endocrinology; 1995 Apr; 136(4):1694-700. PubMed ID: 7895680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone remodelling markers and serum cytokines in patients with hyperthyroidism.
    Akalin A; Colak O; Alatas O; Efe B
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):125-9. PubMed ID: 12100080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study.
    Glinoer D; de Nayer P; Bex M;
    Eur J Endocrinol; 2001 May; 144(5):475-83. PubMed ID: 11331213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
    Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.